NSEAllotment of Securities22 Jun 2026 · 22 Jun 2026, 05:03 pm
Allotment of Securities
Sai Life Sciences Limited · SAILIFE
✦ AI SummaryFundraise
Sai Life Sciences Limited has allotted 170,501 fully paid-up equity shares of Re. 1/- each to employees who exercised options granted under its ESOP 2008 and MESOP 2018 schemes. This allotment, approved on June 22, 2026, increases the total issued shares to 21,22,86,016. The shares were issued at varying exercise prices of Rs. 188.90, Rs. 23.30, and Rs. 127.30, resulting in a minor capital inflow for the company.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sai Life Sciences Limited has informed the Exchange regarding allotment of 170501 securities pursuant to ESOP/ESPS at its meeting held on Jun 22, 2026
Attachments (1)
📄pdf
Download →
SAILIFE_22062026170222_LODR_Intimation_of_Allotment.pdf
View document text
Date: 22 June 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Dalal Street Exchange Plaza, C-1, Block G, Bandra Kurla
Mumbai – 400001 Complex, Bandra (E), Mumbai – 400 051
BSE Scrip Code: 544306 NSE Scrip Symbol: SaiLife
Sub: Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Allotment of
equity shares under Employees Stock Option Plan 2008 (“ESOP 2008”) and
Management ESOP Plan 2018 (“MESOP 2018”).
Dear Sir/ Madam,
Pursuant to Regulation 30 read with Schedule III to the Securities and Exchange Board of India
(Listing Obligation and Disclosure Requirements) Regulation, 2015 (“Listing Regulations”),
we wish to inform you that the Board of Directors of the Company has approved and allotted
5,002 and 1,65,499 fully paid-up equity shares of Rs.1/ each upon exercise of options granted
under ESOP 2008 and MESOP 2018 respectively vide circular resolution dated 22 June, 2026.
The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and
Sweat Equity) Regulations, 2021 are enclosed herewith as Annexure-A.
Further, the details required as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated
11 November 2024 are enclosed as Annexure-B.
We request you to take note of the same and oblige.
Thank you.
For Sai Life Sciences Limited
Runa Karan
Company Secretary & Compliance Officer
Membership No.: A13721
Encl: As above
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.
Annexure - A
Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity)
Regulations, 2021.
1 Company name and address of Registered Office:
Sai Life Sciences Limited
Plot No. DS-7, IKP Knowledge Park, Turkapally (V) Shameerpet Mandal, Medchal-
Malkajgiri Dist, Rangareddi, Hyderabad, Telangana, India, 500078
2 Name of the Stock Exchanges on which the company’s shares are listed:
BSE Limited (“BSE”)
National Stock Exchange of India Limited (“NSE”)
3 Filing date of the statement referred in regulation 10(b) of the SEBI (Share Based
Employee Benefits and Sweat Equity) Regulations, 2021 with Stock Exchange:
08 January 2025 (BSE & NSE)
4 Filing Number, if any:
ESOP 2008 MESOP 2018
BSE 220872 BSE 220874
NSE 46558 NSE 46557
5 Title of the Scheme pursuant to which shares are issued, if any:
Employees Stock Option Plan 2008
Management ESOP Plan 2018
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 1/- per share
8 Date of issue of shares: 22 June 2026 (Allotment on exercise of options)
9 Number of shares issued: 1,70,501
10 Share Certificate No., if applicable: Not Applicable. Shares are issued in
Dematerialized form
11 Distinctive number of the share, if applicable: 21,21,15,516 to 21,22,86,016 (both
inclusive)
12 ISIN Number of the shares if issued in Demat: INE570L01029
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.
13 Exercise price per share:
Rs. 188.90/- per share per allotment of 5002 shares (ESOP 2008)
Rs. 23.30/- per share per allotment of 30,499 shares (MESOP 2018)
Rs. 127.30/- per share per allotment of 1,35,000 shares (MESOP 2018)
14 Premium per share:
Rs. 187.90/- per share (ESOP 2008)
Rs. 22.30/- per share (MESOP 2018)
Rs. 126.30/- per share (MESOP 2018)
15 Total Issued shares after this issue: 21,22,86,016
16 Total Issued share capital after this issue: 21,22,86,016
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they
become identical: NA
20 Details of listing fees, if payable: NA
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.
Annexure-B
Details required under Regulation 30 read with Schedule III of the Listing Regulations and
as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024.
Sl. Disclosures Particulars
a) brief details of options The present instance is for allotment of shares upon
granted exercise of 5,002 and 1,65,499 options under ESOP
2008 and MESOP 2018 respectively.
b) Whether the scheme is in Yes
terms of SEBI (SBEB)
Regulations, 2021 (if
applicable)
c) total number of shares covered The present disclosure is in respect of allotment of
by these options 1,70,501 shares made on 22 June 2026.
d) pricing formula The price payable by an Employee on Exercise is
determined by the Nomination and Remuneration
Committee and in conformity with applicable
accounting Standards, the SEBI SBEB & SE
Regulations as applicable from time to time.
e) options vested NA as the intimation is towards allotment of shares
pursuant to exercise of ESOPs
f) time within which option may NA as the intimation is towards allotment of shares
be exercised pursuant to exercise of ESOPs
g) options exercised The present instance is for allotment of shares upon
exercise of 5,002 and 1,65,499 options under ESOP
2008 and MESOP 2018 respectively.
h) money realized by exercise of INR 1,88,41,004.50
options
i) the total number of shares 1,70,501
arising as a result of exercise of
option
j) options lapsed NA as the intimation is towards allotment of shares
pursuant to exercise of ESOPs
k) variation of terms of options NA
l) brief details of significant The objective of ESOP 2008 and MESOP 2018
terms (“ESOP Plans”) are to provide an incentive to
attract, retain and reward employees and
contribute to the growth of the Company. The
ESOP Plans have a maximum vesting period of 5
years with multiple options of vesting as per clause
5 of the ESOP Plans. The exercise period is till the
employee is in the service of the company as per
clause 7 of ESOP Plans.
m) subsequent changes or NA
cancellation or exercise of such
options
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.
n) diluted earnings per share NA
pursuant to issue of equity
shares on exercise of options
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.